Skip to main content

The Future of Medicine: AI Could Deliver Life-Saving Drugs by the End of 2025!

The pharmaceutical industry is keen to turn AI-generated drug formulas into life-saving treatments. Isomorphic Labs, a spin-off of Google DeepMind, is on track to start testing its first AI-designed drugs within the year.

“We are aiming to have AI-designed drugs entering clinical trials by the end of 2025,” said Demis Hassabis, CEO of Isomorphic Labs and a Nobel Prize laureate, during a panel discussion at the World Economic Forum in Davos. “That’s our goal.”

The potential of AI in drug discovery is vast. Instead of spending years manually testing compounds, AI can analyze large datasets to detect patterns and predict which molecules might evolve into breakthrough drugs. This could dramatically accelerate the development process, reduce costs, and potentially unlock new cures.

Currently, there are more than 460 AI startups working on drug discovery, with over a quarter of them based in Europe. To date, the sector has seen investments surpassing $60 billion, with funding continuing to grow.

However, drug discovery is only part of the equation. The real impact will come when major pharmaceutical companies decide to scale up production and bring these drugs to market. This is why partnerships between AI-driven companies and big pharma are particularly exciting.

In 2024, Isomorphic Labs secured a $45 million deal with Eli Lilly to advance AI-based research into small molecule therapeutics. This agreement could also see Isomorphic earn up to $1.7 billion in performance-based milestones. Additionally, the company has partnered with Swiss biotech firm Novartis.

“We’re already working on real drug programs,” Hassabis told Bloomberg Television following these announcements. “We expect to see the first AI-designed drugs in clinical trials within the next few years.”

Exscientia, a company that emerged from Dundee University in 2012, was one of the first to apply AI to drug discovery. In 2024, Exscientia advanced its first AI-designed drug candidate into human trials within a year—a process that typically takes five years. The US-based company Recursion acquired Exscientia for $688 million in November.

These are just two of the most prominent examples in a booming AI drug discovery market, which is also experiencing consolidation. Smaller companies are also exploring specialized applications, such as CardiaTec, based in Cambridge, UK, which uses AI to develop treatments for heart conditions, and Multiomic Health in London, which is focused on metabolic diseases.

While AI promises to accelerate the drug discovery process, it’s not a one-size-fits-all solution. While AI can speed up the identification of viable drug candidates, the time-consuming stages—such as physical lab tests, clinical trials, and regulatory approvals—will still require traditional approaches. However, AI's true strength lies in its ability to pinpoint promising drug candidates early, saving researchers valuable time and potentially unveiling new therapeutic possibilities.

 

Comments

Post a Comment

Popular posts from this blog

India partners with US, UK, Saudi Arabia, and UAE to safeguard its citizens in Sudan

India is reportedly working in close coordination with the United States, the United Kingdom, Saudi Arabia, and the United Arab Emirates (UAE) to ensure the safety and security of its citizens in Sudan. According to sources, the Indian government has been in touch with the relevant authorities in these countries to take necessary measures to safeguard the interests of its citizens in Sudan. The decision to coordinate with these countries comes in the wake of recent political turmoil in Sudan, which has led to concerns about the safety of foreign nationals in the country. The Indian government has been closely monitoring the situation and has advised its citizens to exercise caution and avoid non-essential travel to Sudan until the situation stabilizes. India has a significant expatriate community in Sudan, including professionals working in various industries such as oil and gas, healthcare, and education. The Indian government is keen to ensure the safety and security of its citizens ...
2 comments
Read more

Content Marketing in 2025: Trends, Tools, and Strategies You Need to Know

As digital marketing continues to evolve, one thing remains clear: content marketing is key to building and maintaining a successful brand. Whether you’re a business owner, marketer, or content creator, understanding the content marketing meaning and how it impacts your business is essential. As we look ahead to 2025, staying on top of content marketing trends and utilizing the right content marketing tools will be critical to your success. In this article, we’ll dive into the content marketing strategy you need to adopt, explore key trends shaping the industry, and look at the best tools and examples to implement today. What is Content Marketing Meaning and Why is it Important? Before we dive into trends and tools, let’s first define content marketing meaning . Simply put, content marketing involves creating and sharing valuable, relevant, and consistent content to attract and engage a target audience. It’s not just about selling—it’s about building trust and relationships...
Post a Comment
Read more

BINARY OPTIONS:Binary Options and How Do You Trade Binary Options?

The Binary option Is a type of option where the payoff is all or nothing, making them easier to comprehend and trade than standard options with a wide range of potential payoffs.  The "cash-or-nothing" binary option and the "asset-or-nothing" binary option are the two primary types of binary options. The asset-or-nothing binary option pays the value of the underlying securities, whereas the cash-or-nothing option pays a preset sum of cash if the option expires in the money. Because there are just two conceivable payment outcomes, these securities are referred to as "binary options." They are also known as fixed return options (FROs), all-or-nothing options, and digital options (popular in forex trading) (on the American Stock Exchange). Since binary options are typically European-style options, only the expiration date can be used to execute them. Let's examine an instance where a binary cash-or-nothing call option on the stock of XYZ Corp. struck at $...
Post a Comment
Read more